Study Shows an HIV Medication Slows Malignant Colorectal Cancer

New clinical research demonstrates that lamivudine, a reverse transcriptase inhibitor often used in HIV treatment, prevented disease progression in 25% of patients with metastatic colorectal cancer who were on their fourth line of treatment